Related Experiment Video
Updated: Mar 26, 2026
10:34
Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
Published on: December 21, 2016
6.8K
Methylation Analysis in Distinct Immune Cell Subsets in Type 1 Diabetes
Mary N Dang1, Claire M Bradford2, Paolo Pozzilli2,3
1Centre for Diabetes and Metabolic Medicine, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK. m.a.n.dang@qmul.ac.uk.
Methods in Molecular Biology (Clifton, N.J.)
|January 22, 2016
Summary
Epigenetic modifications, like DNA methylation, influence gene expression and can be inherited. Studying cell-specific DNA methylation is crucial for understanding diseases like type 1 diabetes.
Area of Science:
- Genetics and Molecular Biology
- Immunology
- Epigenetics
Background:
- Epigenetics describes how environmental factors interact with genotype, influencing phenotypes.
- Epigenetic modifications, such as DNA methylation, alter gene expression and can be mitotically inherited.
- Previous studies on DNA methylation in disease used peripheral blood mononuclear cells, which can confound results due to varying cell type compositions.
Purpose of the Study:
- To highlight the importance of identifying cell- or tissue-specific DNA methylation changes.
- To emphasize the need for such analysis in autoimmune diseases, specifically type 1 diabetes.
Main Methods:
- Review of existing literature on epigenetics and DNA methylation.
- Analysis of the limitations of previous studies using mixed cell populations.
- Focus on the necessity of cell-type-specific epigenetic profiling.
Main Results:
- Cellular heterogeneity in peripheral blood can obscure true disease-specific epigenetic signatures.
- DNA methylation profiles differ significantly across distinct cell subsets.
- Understanding these cell-specific profiles is key to accurate disease association.
Conclusions:
- Cell- and tissue-specific DNA methylation analysis is essential for identifying reliable disease biomarkers.
- This approach is particularly critical for complex autoimmune diseases like type 1 diabetes.
- Future research should prioritize high-resolution epigenetic studies in specific cell types.
